1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Halo Collective Inc.

Halo Collective Inc.

HCANF
Halo Collective Inc.US flagOther OTC
0.00
USD
- -
- -
15,081.00Market Cap
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
1,743.72
1,432.57
382.2
157.51
3.09
0.3
Basic EPS, GAAP
-12,601.36
-8,084.59
-5,795.64
-58,494.64
120.38
326.71
-364.39
-1,062.42
-2,194.85
-1,405.52
-727.32
-411.9
-10.55
-1.17
Free Cash Flow per Basic Share
-8,564.98
-12,141.44
-4,747.34
-717.42
-596.1
-255.13
-249.01
-436.78
-2,515.71
-853.09
-240.49
-167.26
-1.75
-0.08
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-50,858.69
77,707.33
64,392.75
-15,756.97
-1,534.03
1,289.48
1,380.73
358.13
1,509.91
955.49
826.42
210.79
1.87
0.07
Tangible Book Value per Share
104,549.05
93,858.3
70,804.29
-8,481.17
3,428.84
1,216.29
1,203.42
579.86
1,597.45
666.37
352.83
162.49
1.96
0.1
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
8
62
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
11
28
22
36
25
18
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
-93.11
-86.14
-98
-116.97
-142.19
-120.25
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
1
2
2
4
3
3
Net Income, GAAP
-6
-4
-3
-41
- -
- -
- -
-1
-14
-28
-41
-95
-84
-72
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
-125.87
-98.11
-190.3
-261.51
-341.78
-393.86
Working Capital
24
6
1
-7
-1
1
1
1
6
15
19
5
5
6
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
9
18
8
14
12
Total Equity
46
43
41
-6
2
1
1
1
15
24
60
66
29
20
Return on Invested Capital (%)
- -
- -
- -
- -
- -
-13.93
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
722.03
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
-9.27
- -
- -
- -
-27.29
-122.2
-281.15
-195.79
-125.62
-198.74
-265.04
-206.67

Capital Structure

FRC

•

in mil. unless spec.
Dec'22
Mar'23
Jun'23
ST Debt
4
4
4
LT Borrowings
10
8
9
LT Finance Leases
4
4
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
50
151
151
Market Capitalization
- -
- -
1

Working Capital

FRC

•

in mil. unless spec.
Dec'22
Mar'23
Jun'23
Total Current Assets
19
20
18
Cash, Cash Equivalents & STI
1
2
1
Accounts Receivable, Net
3
2
2
Inventories
12
11
10
Total Current Liabilities
14
13
12
Payables & Accruals
10
9
8
ST Debt
4
4
4
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
254.11%
580.57%
-55.71%
Free Cash Flow
394.88%
803.86%
-63.85%
Net Income, GAAP
284.32%
321.65%
-11.36%
Sales/Revenue/Turnover
- -
- -
-32.18%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
10
9
9
8
36
2022
8
7
6
5
25
2023
5
4
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
-56.32
-57.04
-40.32
- -
-411.9
2022
-27.53
-8.04
-1.11
- -
-10.55
2023
-0.21
-0.05
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Marshall Minor
Full Time Employees
114
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
77 King Street West Toronto ON Canada M5K 0A1
IPO Date
Sep 22, 2010
CIK
0001520211
Website
haloco.com
Similar Companies
JW Pharmaceutical Corporation (001060.KS)
Next Science Limited (NXSCF)
AstraZeneca Pharma India Limited (ASTRAZEN.BO)
Grown Rogue International Inc. (GRUSF)
Laurus Labs Limited (LAURUSLABS.BO)
Imagenetix, Inc. (IAGX)
Business
Halo Collective Inc. (HCANF) is a vertically integrated cannabis company that cultivates, extracts, manufactures, and distributes cannabis flower, pre-rolls, vape carts, edibles, and concentrates primarily in the United States. The company offers concentrates including shatter, sauce, live resin, badder, hash, rosin, and THC-A crystals; raw and distilled oils in various strains, flavors, cannabinoid ratios, and blends; cannabis-derived terpene distillate vapor, botanical terpene, and live resin cartridges; as well as edibles such as single- and multi-piece chews, cannabis-infused gummies, and syrup-based drinks, sold under brands including Hush, Winberry Farms, Mojave, and Exhale through dispensaries and distribution centers in California, Oregon, and Nevada. Founded in 2016 and headquartered in Toronto, Canada, with operations centered on the U.S. West Coast, Halo Collective targets recreational and medical cannabis markets via its retail brand Budega and partnerships with entities such as OG DNA Genetics, Terphogz (Zkittlez), and FlowerShop; it previously changed its name from Halo Labs Inc. in January 2021. Recent developments include securing a convertible promissory note facility for up to C$5 million with Reef in November 2022, of which approximately $3.95 million was drawn; completing the acquisition of Pistil Point assets in Oregon for US$4.0 million to enhance vertical integration; and expanding Budega retail locations with three sites operational in Los Angeles areas like North Hollywood and Westwood, alongside plans for up to seven additional stores by late 2023 amid highest-selling quarterly revenues.

Company News

APIChatGPT

  • newsfilecorp.com

    Halo Collective Reports Q2 2023 Financial Results and Announces Delisting

  • newsfilecorp.com

    Halo Collective Provides Fourth Quarter 2022, First Quarter 2023 Financial Results

  • seekingalpha.com

    Halo Collective Inc. (HCANF) CEO Kiran Sidhu on Q1 2022 Results - Earnings Call Transcript

  • seekingalpha.com

    Halo Collective Inc.'s (HCANF) CEO Kiran Sidhu on Q4 2021 Results - Earnings Call Transcript

  • benzinga.com

    Halo Collective Expands Into Functional Drinks Via H2C Beverages Acquisition & $30M Deal With Elegance Brands

  • benzinga.com

    Halo Collective Borrows CA$14M To Fund Expansion Into Nutraceutical Products And Retail